Mei Bai

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

18 h-index 76 pubs 1,377 cited

Biography and Research Information

OverviewAI-generated summary

Mei Bai's research investigates the molecular mechanisms underlying various disease states, with a focus on the role of natural compounds and specific cellular pathways. Recent work includes studying the direct inhibition of GSDMD by PEITC to reduce hepatocyte pyroptosis and alleviate acute liver injury in mice, as well as the amelioration of chemotherapeutic intestinal injury by PEITC through the suppression of neutrophil extracellular traps. Bai has also explored how STAT3 activates lncRNA NR2F1‐AS1 to promote melanoma progression and how the natural compound fraxinellone intervenes in the HSP47-collagen interaction to ameliorate intestinal fibrosis. Other studies have examined the association of Fc receptor-like variants with rheumatoid arthritis risk and the potential of HINT2 as a clinical target for diabetes mellitus by reducing ROS-induced oxidative stress and ferroptosis. Bai's scholarship is supported by 76 publications, with an h-index of 18 and 1,357 total citations.

Metrics

  • h-index: 18
  • Publications: 76
  • Citations: 1,377

Selected Publications

  • Psychological Adaptation to Newly Diagnosed Advanced Cancer (2025)
  • Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial (2025)
    2 citations DOI OpenAlex
  • Psychological Response to the Diagnosis of Advanced Cancer: A Systematic Review (2021)
    13 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

82 Collaborators 31 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics